Clear ×
Sunshine Biopharma Inc. SBFM

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Aug 28, 2026 8-K 1 signal fired
Other
Classified Board Director Election
Aug 13, 2026 10-Q 30 signals fired · top 15
Other
Liquidity Position Snapshot Disclosed Reverse Stock Split Effected Net Loss Reported Ipo Or Capital Raising Completion Revenue Decline Explanation Quarterly Tax Provision Benefit Disclosure Shares Outstanding Disclosure Financing Activities Cash Flow Disclosure Interest Income Year Over Year Comparison Tax Cuts And Jobs Act Disclosure Cash Flow Statement Investing Activities Personnel Cost Decrease Disclosure Gross Profit Year Over Year Comparison Valuation Allowance Deferred Tax Disclosure
Business Services
Demand Softening
Jul 20, 2026 8-K 23 signals fired · top 15
Other
Nyse Listing Disclosure Sanctions Compliance Representation Legal Opinion Methodology Disclosure Corporate Authority Representation Corporate Organization And Standing Representation Indemnification Consent Requirement Prospectus Supplement Disclosure Conflicted Defense Counsel Provision Legal Opinion Scope Limitation Fcpa Compliance Representation Form S3 Shelf Registration Disclosure Use Of Proceeds Disclosure No Regulatory Approval Required Registration Rights Piggyback Provision Survival Of Representations Warranties Clause
Jul 10, 2026 8-K 0 signals fired
No signals above threshold for this filing.
May 19, 2026 8-K 9 signals fired
Other
Form S3 Shelf Registration Disclosure Ipo Net Proceeds Disclosure Institutional Investment Mrna Drug Platform Ipo Or Capital Raising Completion Warrant Exercise Share Delivery Warrant Redemption Cashless Exercise Provision
Core
Indication Expansion Lead Asset Progress
May 13, 2026 10-Q 20 signals fired · top 15
Other
Liquidity Position Snapshot Disclosed Codm Segment Reporting Disclosure Net Loss Reported Cash Flow Statement Investing Activities Shares Outstanding Disclosure Valuation Allowance Deferred Tax Disclosure Gross Profit Year Over Year Comparison Revenue Increase Attribution Disclosure Incorporation Or Reincorporation Disclosure Capital Raising Uncertainty Disclosed Tax Cuts And Jobs Act Disclosure Segment Aggregation Disclosure Financing Activities Cash Flow Disclosure
Business Services
Demand Softening
Core
Management Exodus
Apr 9, 2026 8-K 3 signals fired
Other
Forward Looking Statement Definition Administrative Efficiency
Core
Indication Expansion
Apr 3, 2026 10-K 45 signals fired · top 15
Other
Liquidity Position Snapshot Disclosed Depreciation Expense Composition Disclosure Deferred Tax Asset Valuation Disclosure Nyse Listing Disclosure Executive Educational Background Disclosure Net Loss Reported Share Repurchase Activity Disclosed Ipo Or Capital Raising Completion Fifo Inventory Valuation Disclosed Auditor Appointment Ratification Incorporation Or Reincorporation Disclosure Pricing Pressure Nol Carryforward Expiration Disclosure Public Float Disclosure
Business Services
Demand Softening
Mar 9, 2026 8-K 1 signal fired
Other
Director Officer Indemnification Provision